SCHEMBL7247328

SCHEMBL7247328

COc1cccc(-c2ccc3c(c2)cc(C(=O)O)n3Cc2ccccc2)c1

nearest known ligand 0.74

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 11/20 0.74
SERPINE1 P05121 1/20 0.54
GPR35 Q9HC97 1/20 0.54
CCR9 P51686 1/20 0.53
PPARG P37231 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9536869 0.88 CCR2 (0.76) CCR2GPR35CCR9
SCHEMBL7245116 0.87 CCR2 (0.79) CCR2SERPINE1GPR35
SCHEMBL3956751 0.86 CCR2 (0.84) CCR2CCR9
SCHEMBL3967526 0.85 CCR2 (1.00) CCR2CCR9
SCHEMBL3956671 0.83 CCR2 (0.77) CCR2GPR35CCR9PPARG
SCHEMBL3963206 0.83 CCR2 (0.79) CCR2GPR35CCR9
SCHEMBL27543171 0.82 CCR2 (0.58) CCR2SERPINE1GPR35
SCHEMBL6303376 0.82 CCR2 (0.78) CCR2CCR9
SCHEMBL3967516 0.81 CCR2 (0.73) CCR2PPARG
SCHEMBL30223430 0.80 ABCB1 (0.72)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1062216-A1 INHIBITORS OF PHOSPHOLIPASE A2 GENETICS INSTITUTE, INC. (US) 2000-12-27 EP claimed
WO-1999043672-A1 INHIBITORS OF PHOSPHOLIPASE A2 GENETICS INSTITUTE, INC. (US) 1999-09-02 WO claimed
US-6630496-B1 Antiinflammatory agents inhibit phospholipase 2, affecting both protaglandin and leukotriene production; indoles substituted in 2 position by 2,4-dioxo-thiazol-3-yl methylidene GENETICS INSTITUTE LLC 2003-10-07 US disclosed
EP-1062216-A1 INHIBITORS OF PHOSPHOLIPASE A2 GENETICS INSTITUTE, INC. (US) 2000-12-27 EP disclosed
WO-1999043672-A1 INHIBITORS OF PHOSPHOLIPASE A2 GENETICS INSTITUTE, INC. (US) 1999-09-02 WO disclosed